Noninvasive quantitative in vivo mapping and metabolism of boronophenylalanine (BPA) by nuclear magnetic resonance (NMR) spectroscopy and imaging

Radiation Research

Volumn 164, Issue 5, 2005, Pages 680-687

  Bendel, Peter ^a   Margalit, Raanan ^a   Koudinova, Natalia ^a   Salomon, Yoram ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

4 BORONOPHENYLALANINE B 10; FRUCTOSE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BORON 11 NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; CONTROLLED STUDY; DISSOCIATION; DRUG CLEARANCE; DRUG EFFICACY; DRUG METABOLISM; DRUG TUMOR LEVEL; DRUG UPTAKE; FEASIBILITY STUDY; IN VIVO STUDY; MALE; MOUSE; NEUTRON CAPTURE THERAPY; NONHUMAN; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; TUMOR XENOGRAFT;

ANIMALS; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; KIDNEY; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLIC CLEARANCE RATE; MICE; MICE, NUDE; PHENYLALANINE; RATS;

ANIMALIA;

EID: 27444435923     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3450.1     Document Type: Article

References (30)

1. R. F. Barth, A critical assessment of boron neutron capture therapy: An overview. J. Neuro-Oncol. 62, 1-5 (2003).
2. M. Thellier, A. Chevallier, I. His, M. C. Jarvis, M. A. Lovell, C. Ripoll, D. Robertson, W. Sauerwein and M-C. Verdus, Methodological developments for application to the study of physiological boron and to boron neutron capture therapy. J. Trace Micropr. Techn. 19, 623-657 (2001).
3. T. U. Probst, Methods for boron analysis in boron neutron capture therapy (BNCT). A review. Fresenius J. Anal. Chem. 364, 391-403 (1999).
4. C. R. Gibson, A. E. Staubus, R. F. Barth, W. L. Yang, A. K. Ferketich and M. M. Moeschberger, Pharmacokinetics of sodium borocaptate: A critical assessment of dosing paradigms for boron neutron capture therapy. J. Neuro-Oncol. 62, 157-169 (2003).
5. J. A. Coderre, A. D. Chanana, D. D. Joel, E. H. Elowitz, P. L. Micca, M. M. Nawrocky, M. Chadha, J. O. Gebbers, M. Shady and D. N. Slatkin, Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: Boron concentration correlates with tumor cellularity. Radiat. Res. 149, 163-170 (1998).
6. 10B in blood after boronophenylalanine-fructose administration in humans. Radiat. Res. 155, 611-618 (2001).
7. 10B in blood after BPA-fructose complex infusion. Phys. Med. Biol. 47, 737-745 (2002).
8. 10B concentration after BPA-fructose complex infusion in patients during epithermal neutron irradiation in BNCT. Int. J. Radiat. Oncol. Biol. Phys. 48, 1145-1154 (2000).
9. Y. Imahori, S. Ueda, Y. Ohmori, T. Kusuki, K. Ono, R. Fujii and T. Ido, Fluorine-18 labeled fluoroboronophenylalanine PET in patients with glioma. J. Nucl. Med. 39, 325-333 (1998).
10. T. L. Nichols, G. W. Kabalka, L. F. Miller, M. K. Khan and G. T. Smith, Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine-18 labeled boronophenylalanine and positron emission tomography. Med. Phys. 29, 2351-2358 (2002).
11. G. W. Kabalka, T. L. Nichols, G. T. Smith, L. F. Miller, M. K. Khan and P. M. Busse, The use of positron emission tomography to develop boron neutron capture therapy treatment plans for metastatic malignant melanoma. J. Neuro-Oncol. 62, 187-195 (2003).
12. 1H MR spectroscopy for clinical use. Progr. Nucl. Magn. Reson. Spectr. 31, 155-195 (1997).
13. J. R. Griffiths and J. D. Glickson, Monitoring pharmacokinetics of anticancer drugs: Non-invasive investigation using magnetic resonance spectroscopy. Adv. Drug Deliv. Rev. 41, 75-89 (2000).
14. I. M. Burtscher and S. Holtas, Proton MR spectroscopy in clinical routine. J. Magn. Reson. Imag. 13, 560-567 (2001).
15. 7Li NMR. NMR Biomed. 18, 67-73 (2005).
16. 19F-MRS studies of fluorinated drugs in humans. Adv. Drug Del. Rev. 41, 55-74 (2000).
17. 19F-magnetic resonance spectroscopy in patients with liver metastases of colorectal cancer treated with 5-fluorouracil. Anti-Cancer Drugs 15, 229-233 (2004).
18. 19F magnetic resonance spectroscopy. Br. J. Clin. Pharmacol. 59, 244-248 (2005).
19. 10B MRI. Magn. Reson. Med. 46, 13-17 (2001).
20. 11B NMR. NMR Biomed. 18, 74-82 (2005).
21. C. S. Zuo, P. V. Prasad, P. Busse, L. Tang and R. G. Zamenhof, Proton nuclear magnetic resonance measurement of p-boronophenylalanine (BPA): A therapeutic agent for boron neutron capture therapy. Med. Phys. 26, 1230-1236 (1999).
22. 10B-carrier, L-p-boronophenylalanine-fructose complex, BPA-F: phantom studies at 1.5 and 3.0 T Phys. Med. Biol. 48, 1027-1039 (2003).
23. 10B-carrier, BPA-F using STEAM and PRESS MRS sequences: Detection limit and quantification. Spectroscopy 18, 133-142 (2004).
24. 1H MRS and MRSI methods for the in-vivo detection of borono-phenylalanine (BPA). Magn. Reson. Med. 53, 1166-1171 (2005).
25. M. Garwood and L. DelaBarre, The return of the frequency sweep: Designing adiabatic pulses for contemporary NMR. J. Magn. Reson. 153, 155-177 (2001).
26. V. Panov, Y. Salomon, G. W. Kabalka and P. Bendel, Uptake and washout of borocaptate sodium and borono-phenylalanine in cultured melanoma cells: A multi-nuclear NMR study. Radiat. Res. 154, 104-112 (2000).
27. S. Chandra, G. W. Kabalka, D. R. Lorey, II, D. R. Smith and J. A. Coderre, Imaging of fluorine and boron from fluorinated boronophenylalanine in the same cell at organelle resolution by correlative ion microscopy and confocal laser scanning microscopy. Clin. Cancer Res. 8, 2675-2683 (2002).
28. D. R. Smith, S. Chandra, R. F. Barth, W. Yang, D. D. Joel and J. A. Coderre, Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: Relevance to neutron capture therapy. Cancer Res. 61, 8179-8187 (2001).
29. 19F-BPA in a mouse melanoma model. In Advances in Neutron Capture Therapy, Vol. II, Chemistry and Biology (B. Larsson, J. Crawford and R. Weinreich, Eds.), pp. 632-639. Elsevier Science, Amsterdam, 1997.
30. K. Yoshino, R. Nakajima, A. Takaoka, Y. Mori, H. Kakihana, Y. Mishima and M. Ichihashi, Determination of released boric acid in vivo after p-boronophenylalanine administration into melanoma-bearing subjects. In Advances in Neutron Capture Therapy, Vol. II, Chemistry and Biology (B. Larsson, J. Crawford and R. Weinreich, Eds.), pp. 334-338. Elsevier Science, Amsterdam, 1997.